HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ceftobiprole medocaril: a new generation beta-lactam.

Abstract
Ceftobiprole is a novel parenteral cephalosporin with high affinity for most penicillin-binding proteins, including the mecA product penicillin-binding protein (PBP) 2a, rendering it active against methicillin-resistant staphylococci. Its in vitro activity against staphylococci and multiresistant pneumococci, combined with its Gram-negative spectrum comparable to that of other extended-spectrum cephalosporins, its stability against a wide range of beta-lactamases and its pharmacokinetic and safety profile make ceftobiprole an attractive new antimicrobial agent. Because of its low water solubility, ceftobiprole is administered intravenously as a prodrug, ceftobiprole medocaril. Ceftobiprole medocaril is generally well tolerated (with the exception of a caramel-like taste disturbance). Ceftobiprole medocaril has been evaluated in two phase III clinical trials for the treatment of complicated skin infections and skin structure infections. Its broad spectrum of activity may allow ceftobiprole to be used as monotherapy for some infections where combination therapy would otherwise be required, especially regimens requiring coverage of methicillin-resistant Staphylococcus aureus (MRSA).
AuthorsJose L Del Pozo, Robin Patel
JournalDrugs of today (Barcelona, Spain : 1998) (Drugs Today (Barc)) Vol. 44 Issue 11 Pg. 801-25 (Nov 2008) ISSN: 1699-3993 [Print] Spain
PMID19180259 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright 2008 Prous Science, S.A.U. or its licensors. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Cephalosporins
  • Prodrugs
  • beta-Lactams
  • ceftobiprole medocaril
Topics
  • Animals
  • Anti-Bacterial Agents (chemistry, metabolism, pharmacology, therapeutic use)
  • Cephalosporins (chemistry, metabolism, pharmacology, therapeutic use)
  • Clinical Trials, Phase III as Topic
  • Humans
  • Injections, Intravenous
  • Molecular Structure
  • Prodrugs (chemistry)
  • beta-Lactams (chemistry, metabolism, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: